Skip to content
DataLookout
Menu

NCT07924345

Observational Study to Evaluate Achieving LDL-cholesterol Target Level to Treat With Rovazet Tab. With Dyslipidemia Patients

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Secondary endpoints: 4 to 1
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

The proportion of study participants who achieve the LDL-C treatment target at Week 24, according to the dyslipidemia treatment guidelines
Timeframe: Day 1 to week 24

Secondary (1)

The proportion of study participants who achieve the LDL-C treatment target at Week 48, according to the dyslipidemia treatment guidelines.

Sites

1 site in 1 country

  • HK inno.N CorporationSeoul, South Korea